Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES vs PFIZER - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDOCO REMEDIES PFIZER INDOCO REMEDIES/
PFIZER
 
P/E (TTM) x 30.0 38.2 78.6% View Chart
P/BV x 2.9 6.0 49.3% View Chart
Dividend Yield % 0.7 1.7 41.0%  

Financials

 INDOCO REMEDIES   PFIZER
EQUITY SHARE DATA
    INDOCO REMEDIES
Mar-23
PFIZER
Mar-23
INDOCO REMEDIES/
PFIZER
5-Yr Chart
Click to enlarge
High Rs4234,662 9.1%   
Low Rs3083,407 9.0%   
Sales per share (Unadj.) Rs181.1530.0 34.2%  
Earnings per share (Unadj.) Rs15.4136.4 11.3%  
Cash flow per share (Unadj.) Rs23.1159.4 14.5%  
Dividends per share (Unadj.) Rs2.2570.00 3.2%  
Avg Dividend yield %0.61.7 35.5%  
Book value per share (Unadj.) Rs111.5701.0 15.9%  
Shares outstanding (eoy) m92.1545.75 201.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.07.6 26.5%   
Avg P/E ratio x23.729.6 80.0%  
P/CF ratio (eoy) x15.825.3 62.5%  
Price / Book Value ratio x3.35.8 57.0%  
Dividend payout %14.651.3 28.4%   
Avg Mkt Cap Rs m33,683184,576 18.2%   
No. of employees `000NANA-   
Total wages/salary Rs m3,2263,317 97.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m16,68624,248 68.8%  
Other income Rs m241,011 2.4%   
Total revenues Rs m16,71025,258 66.2%   
Gross profit Rs m2,8608,420 34.0%  
Depreciation Rs m7061,055 66.9%   
Interest Rs m250135 185.7%   
Profit before tax Rs m1,9288,240 23.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5052,001 25.3%   
Profit after tax Rs m1,4236,239 22.8%  
Gross profit margin %17.134.7 49.4%  
Effective tax rate %26.224.3 108.0%   
Net profit margin %8.525.7 33.1%  
BALANCE SHEET DATA
Current assets Rs m8,08224,933 32.4%   
Current liabilities Rs m4,2456,574 64.6%   
Net working cap to sales %23.075.7 30.4%  
Current ratio x1.93.8 50.2%  
Inventory Days Days2593 26.8%  
Debtors Days Days7682 33,610.5%  
Net fixed assets Rs m9,05513,780 65.7%   
Share capital Rs m184458 40.3%   
"Free" reserves Rs m10,09231,616 31.9%   
Net worth Rs m10,27632,073 32.0%   
Long term debt Rs m1,4350-   
Total assets Rs m17,13739,031 43.9%  
Interest coverage x8.762.1 14.0%   
Debt to equity ratio x0.10-  
Sales to assets ratio x1.00.6 156.7%   
Return on assets %9.816.3 59.8%  
Return on equity %13.819.5 71.2%  
Return on capital %18.626.1 71.2%  
Exports to sales %47.52.8 1,673.1%   
Imports to sales %11.50 33,168.4%   
Exports (fob) Rs m7,919688 1,151.3%   
Imports (cif) Rs m1,9178 22,825.0%   
Fx inflow Rs m7,919688 1,151.3%   
Fx outflow Rs m1,9178 22,825.0%   
Net fx Rs m6,002679 883.4%   
CASH FLOW
From Operations Rs m1,7883,557 50.3%  
From Investments Rs m-2,082-361 577.5%  
From Financial Activity Rs m228-3,458 -6.6%  
Net Cashflow Rs m-65-262 25.0%  

Share Holding

Indian Promoters % 58.7 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 21.3 18.2 116.9%  
FIIs % 1.7 3.0 55.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 41.3 36.1 114.4%  
Shareholders   32,600 112,456 29.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDOCO REMEDIES With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Indoco Remedies vs Pfizer

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Indoco Remedies vs Pfizer Share Price Performance

Period Indoco Remedies Pfizer S&P BSE HEALTHCARE
1-Day -1.81% -4.80% 1.18%
1-Month -6.44% -8.24% -0.75%
1-Year 1.11% 21.78% 61.82%
3-Year CAGR 4.71% -2.07% 18.16%
5-Year CAGR 11.97% 4.95% 19.79%

* Compound Annual Growth Rate

Here are more details on the Indoco Remedies share price and the Pfizer share price.

Moving on to shareholding structures...

The promoters of Indoco Remedies hold a 58.7% stake in the company. In case of Pfizer the stake stands at 63.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Indoco Remedies and the shareholding pattern of Pfizer.

Finally, a word on dividends...

In the most recent financial year, Indoco Remedies paid a dividend of Rs 2.3 per share. This amounted to a Dividend Payout ratio of 14.6%.

Pfizer paid Rs 70.0, and its dividend payout ratio stood at 51.3%.

You may visit here to review the dividend history of Indoco Remedies, and the dividend history of Pfizer.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.